DK0808173T3 - Produkt og fremgangsmåde til forebyggelse af smitte med respiratorisk virus - Google Patents

Produkt og fremgangsmåde til forebyggelse af smitte med respiratorisk virus

Info

Publication number
DK0808173T3
DK0808173T3 DK96904605T DK96904605T DK0808173T3 DK 0808173 T3 DK0808173 T3 DK 0808173T3 DK 96904605 T DK96904605 T DK 96904605T DK 96904605 T DK96904605 T DK 96904605T DK 0808173 T3 DK0808173 T3 DK 0808173T3
Authority
DK
Denmark
Prior art keywords
prevention
product
virus infection
respiratory virus
virus
Prior art date
Application number
DK96904605T
Other languages
Danish (da)
English (en)
Inventor
Joseph Paul Schaller
Milo Duane Hilty
Jin-Zhou Liu
Steven Neal Anderson
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23526176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0808173(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0808173T3 publication Critical patent/DK0808173T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Water Treatments (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Water Treatment By Sorption (AREA)
  • Materials For Medical Uses (AREA)
DK96904605T 1995-02-10 1996-02-08 Produkt og fremgangsmåde til forebyggelse af smitte med respiratorisk virus DK0808173T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/386,576 US5922344A (en) 1995-02-10 1995-02-10 Product for prevention of respiratory virus infection and method of use
PCT/US1996/001790 WO1996031186A2 (fr) 1995-02-10 1996-02-08 Produit et procede de prevention d'infection virale des voies respiratoires

Publications (1)

Publication Number Publication Date
DK0808173T3 true DK0808173T3 (da) 2002-11-04

Family

ID=23526176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96904605T DK0808173T3 (da) 1995-02-10 1996-02-08 Produkt og fremgangsmåde til forebyggelse af smitte med respiratorisk virus

Country Status (11)

Country Link
US (1) US5922344A (fr)
EP (1) EP0808173B1 (fr)
JP (1) JP2002517167A (fr)
AT (1) ATE222771T1 (fr)
AU (1) AU4866696A (fr)
CA (1) CA2212562A1 (fr)
DE (1) DE69623261T2 (fr)
DK (1) DK0808173T3 (fr)
ES (1) ES2184853T3 (fr)
PT (1) PT808173E (fr)
WO (1) WO1996031186A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701026D0 (sv) * 1997-03-20 1997-03-20 Immun System Ims Ab use of avian antibodies
ES2286558T5 (es) * 2004-08-24 2013-10-15 N.V. Nutricia Composición nutritiva que comprende transgalactooligosacáridos indigeribles y sacáridos de galactosa digeribles
US20100040606A1 (en) * 2006-03-06 2010-02-18 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
KR101423586B1 (ko) * 2006-08-25 2014-07-25 폴 코포레이션 정화 요소를 포함하는 유체 조립체
KR20090127341A (ko) * 2007-03-06 2009-12-10 심포젠 에이/에스 호흡기세포 융합 바이러스 감염 치료용 재조합 항체
BRPI0817257A2 (pt) * 2007-09-24 2015-06-16 Univ Vanderbilt Anticorpos moniclonais para vírus sincital respiratório e usos dos mesmos
US20230397620A1 (en) * 2022-06-08 2023-12-14 Bby, Inc. Powderization of Human Milk

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911108A (en) * 1973-02-14 1975-10-07 Diamond Shamrock Corp Process of producing bovine milk products containing specific antibodies
US5066491A (en) * 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
CA2040770A1 (fr) * 1990-04-19 1991-10-20 James F. Young Administration d'anticorps monoclonaux diriges contre les virus respiratoires
EP0539522B1 (fr) * 1990-07-19 1998-12-30 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Procede immunotherapeutique ameliore pour la prevention ou le traitement des maladies virales des voies respiratoires
ES2181673T3 (es) * 1991-05-01 2003-03-01 Jackson H M Found Military Med Procedimiento de tratamiento de las enfermedades respiratorias infecciosas.
AU3660893A (en) * 1993-01-29 1994-08-15 Med Immune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
JPH06345668A (ja) * 1993-06-07 1994-12-20 Shibayagi:Kk 感染防御組成物およびその用途

Also Published As

Publication number Publication date
EP0808173B1 (fr) 2002-08-28
CA2212562A1 (fr) 1996-10-10
WO1996031186A2 (fr) 1996-10-10
DE69623261D1 (de) 2002-10-02
PT808173E (pt) 2003-01-31
MX9706098A (es) 1997-10-31
EP0808173A2 (fr) 1997-11-26
DE69623261T2 (de) 2003-04-17
JP2002517167A (ja) 2002-06-11
US5922344A (en) 1999-07-13
WO1996031186A3 (fr) 1996-11-14
ATE222771T1 (de) 2002-09-15
ES2184853T3 (es) 2003-04-16
AU4866696A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
NO20083958L (no) Prodrugs av GABA-analoger, sammensetninger og anvendelse derav
NZ515392A (en) Respiratory syncytial virus replication inhibitors
NO985821L (no) Substituerte syklopentanforbindelser som er nyttige som neuraminidaseinhibitorer
TW200501985A (en) Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
ATE476983T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege
ATE250937T1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
ATE427129T1 (de) Abgabevorrichtung fur arzneimittel
DK0640128T3 (da) Vaccinesammensætninger indeholdende attenueret respiratorisk syncytialvirus
CY1108101T1 (el) Ενωσεις πυριμιδινης και η χρηση τους στην παρασκευη ενος τριαζολο-πυριμιδιν καρβα νουκλεοζιτη
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
BR9814375A (pt) Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas
DK0783525T3 (da) Humaniserede antistoffer mod respiratorisk syncytialvirus
HUP0302636A2 (hu) Hasított burkolt víruskészítmény
DE69634045D1 (de) Antithrombotische diamine
CY1110873T1 (el) Σταθεροποιημενα σκευασματα αντισωματων anti-rsv, υγρης μορφης
TW200618810A (en) Treatment of respiratory syncytial virus (RSV) infection
DK1079857T3 (da) Meningitidis B/C-kombinationsvacciner
BR0211296A (pt) Peptìdeo imunogênico derivado da proteìna g do vrs do sub-grupo a ou b, sequência de ácido nucleico, composição farmacêutica, anticorpos policlonais ou monoclonais, kit de diagnóstico, utilização de um peptìdeo imunogênico, e, conjugado
FR2723740B1 (fr) Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
EP0652011A4 (fr) Agent prophylactique et agent curatif contre des maladies virales des voies respiratoires.
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
DK0808173T3 (da) Produkt og fremgangsmåde til forebyggelse af smitte med respiratorisk virus
WO2022015573A3 (fr) Protéines de liaison à l'antigène du sars-cov-2 et leurs utilisations
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
NZ505894A (en) Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases